JPMorgan Chase & Co’s Castle Biosciences CSTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$544K Sell
26,663
-3,914
-13% -$79.9K ﹤0.01% 4022
2025
Q1
$612K Sell
30,577
-77,359
-72% -$1.55M ﹤0.01% 3907
2024
Q4
$2.88M Buy
107,936
+38,527
+56% +$1.03M ﹤0.01% 3165
2024
Q3
$1.98M Buy
69,409
+43,241
+165% +$1.23M ﹤0.01% 3273
2024
Q2
$570K Sell
26,168
-49,975
-66% -$1.09M ﹤0.01% 3797
2024
Q1
$1.69M Buy
76,143
+25,777
+51% +$571K ﹤0.01% 3258
2023
Q4
$1.09M Sell
50,366
-2,297
-4% -$49.6K ﹤0.01% 3485
2023
Q3
$889K Buy
52,663
+1,165
+2% +$19.7K ﹤0.01% 3453
2023
Q2
$707K Buy
51,498
+7,170
+16% +$98.4K ﹤0.01% 3604
2023
Q1
$1.01M Buy
44,328
+8,930
+25% +$203K ﹤0.01% 3447
2022
Q4
$833K Buy
35,398
+2,449
+7% +$57.6K ﹤0.01% 3471
2022
Q3
$860K Buy
32,949
+2,826
+9% +$73.8K ﹤0.01% 3455
2022
Q2
$661K Buy
30,123
+5,799
+24% +$127K ﹤0.01% 3723
2022
Q1
$1.09M Buy
24,324
+754
+3% +$33.8K ﹤0.01% 3552
2021
Q4
$1.01M Buy
23,570
+1,477
+7% +$63.3K ﹤0.01% 3665
2021
Q3
$1.47M Buy
22,093
+4,899
+28% +$326K ﹤0.01% 3369
2021
Q2
$1.26M Sell
17,194
-15,078
-47% -$1.11M ﹤0.01% 3503
2021
Q1
$2.21M Buy
32,272
+9,802
+44% +$671K ﹤0.01% 3184
2020
Q4
$1.51M Buy
22,470
+13,903
+162% +$934K ﹤0.01% 3147
2020
Q3
$433K Sell
8,567
-1,698
-17% -$85.8K ﹤0.01% 3440
2020
Q2
$387K Sell
10,265
-2,277
-18% -$85.8K ﹤0.01% 3393
2020
Q1
$374K Buy
12,542
+10,855
+643% +$324K ﹤0.01% 3424
2019
Q4
$58K Buy
1,687
+476
+39% +$16.4K ﹤0.01% 4189
2019
Q3
$22K Buy
+1,211
New +$22K ﹤0.01% 4462